[ CAS No. 2923-28-6 ]

Name: 2923-28-6|Silver(I) trifluoromethanesulfonate|98%
Brand: Ambeed
SKU: A634214
Price: 5.0 USD
Availability: InStock
Rating: 98 (27 reviews)

{[proInfo.proName]} ,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

2D 3D

Structure of 2923-28-6 * Storage: {[proInfo.prStorage]}

Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 100K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 2923-28-6 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 2923-28-6 ]

SDS Specification

Alternatived Products of [ 2923-28-6 ]

Product Details of [ 2923-28-6 ]

CAS No. :	2923-28-6	MDL No. :	MFCD00013226
Formula :	CAgF₃O₃S	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	QRUBYZBWAOOHSV-UHFFFAOYSA-M
M.W :	256.94	Pubchem ID :	76223
Synonyms :

Calculated chemistry of [ 2923-28-6 ]

Physicochemical Properties

Num. heavy atoms :	9
Num. arom. heavy atoms :	0
Fraction Csp3 :	1.0
Num. rotatable bonds :	1
Num. H-bond acceptors :	6.0
Num. H-bond donors :	0.0
Molar Refractivity :	15.8
TPSA :	65.58 Å²

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-7.64 cm/s

Lipophilicity

Log Po/w (iLOGP) :	0.0
Log Po/w (XLOGP3) :	0.32
Log Po/w (WLOGP) :	2.39
Log Po/w (MLOGP) :	-0.39
Log Po/w (SILICOS-IT) :	2.23
Consensus Log Po/w :	0.91

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-1.57
Solubility :	6.94 mg/ml ; 0.027 mol/l
Class :	Very soluble
Log S (Ali) :	-1.26
Solubility :	14.1 mg/ml ; 0.0549 mol/l
Class :	Very soluble
Log S (SILICOS-IT) :	-0.1
Solubility :	205.0 mg/ml ; 0.798 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	2.0 alert
Leadlikeness :	0.0
Synthetic accessibility :	2.16

Safety of [ 2923-28-6 ]

Signal Word:	Danger	Class:	8
Precautionary Statements:	P264-P280-P302+P352-P305+P351+P338+P310-P332+P313-P362+P364	UN#:	1759
Hazard Statements:	H315-H318	Packing Group:	Ⅲ
GHS Pictogram:

Application In Synthesis of [ 2923-28-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Upstream synthesis route of [ 2923-28-6 ]
Downstream synthetic route of [ 2923-28-6 ]

[ 2923-28-6 ] Synthesis Path-Upstream 1~13

1
[ 2923-28-6 ]
[ 74-88-4 ]
[ 333-27-7 ]

Reference： [1] Journal of Organic Chemistry, 1974, vol. 39, # 26, p. 3875 - 3877
[2] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry, [3] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 2887 - 2891
[4] , Gmelin Handbook: F: PerFHalOrg.SVol.3, 6.2.3.1, page 48 - 120,
[5] Journal of Organic Chemistry, 1974, vol. 39, # 26, p. 3875 - 3877
[6] Journal of the Chemical Society, [7] Journal of the Chemical Society, 1956, p. 173 - 180
[8] , Gmelin Handbook: F: PerFHalOrg.2, 1.3.1, page 76 - 99,
[9] Patent: US2018/298037, 2018, A1, . Location in patent: Paragraph 0080-0083

2
[ 2923-28-6 ]
[ 18162-48-6 ]
[ 69739-34-0 ]

Reference： [1] Journal of the American Chemical Society, 1982, vol. 104, # 22, p. 6092 - 6099

3
[ 123-91-1 ]
[ 7440-55-3 ]
[ 17455-13-9 ]
[ 2923-28-6 ]
[ 1195-66-0 ]

Reference： [1] Journal of the American Chemical Society, 2016, vol. 138, # 40, p. 13119 - 13122

4
[ 123-91-1 ]
[ 7440-55-3 ]
[ 17455-13-9 ]
[ 1125-88-8 ]
[ 2923-28-6 ]
[ 72824-04-5 ]
[ 22039-97-0 ]
[ 1195-66-0 ]

Reference： [1] Journal of the American Chemical Society, 2016, vol. 138, # 40, p. 13119 - 13122

5
[ 1483-72-3 ]
[ 2923-28-6 ]
[ 66003-76-7 ]

Reference： [1] Tetrahedron, 2000, vol. 56, # 6, p. 855 - 863

6
[ 1493-13-6 ]
[ 20667-12-3 ]
[ 2923-28-6 ]

Reference： [1] Dalton Transactions, 2014, vol. 43, # 4, p. 1589 - 1598
[2] Polyhedron, 1996, vol. 15, # 24, p. 4349 - 4354
[3] Journal of the Chemical Society, [4] Journal of the Chemical Society, 1955, p. 2901 - 2910
[5] Journal of the Chemical Society, [6] Journal of the Chemical Society, 1956, p. 173 - 180
[7] Journal of the Chemical Society, [8] Journal of the Chemical Society, 1957, p. 2640 - 2645
[9] C.A., 1956, p. 13982
[10] Patent: US2732398, 1954, ,
[11] Journal of the Chemical Society, [12] Journal of the Chemical Society, 1954, p. 4228 - 4232
[13] , Gmelin Handbook: F: PerFHalOrg.2, 1.3.1, page 76 - 99,
[14] Chemistry - A European Journal, 2015, vol. 21, # 28, p. 10070 - 10081

7
[ 1493-13-6 ]
[ 2923-28-6 ]

Reference： [1] Patent: US3962224, 1976, A,

8
[ 1493-13-6 ]
[ 2923-28-6 ]

Reference： [1] Zeitschrift fuer Physikalische Chemie (Muenchen, Germany), 1983, vol. 138, p. 137 - 156
[2] C.A., 1976, vol. 85, p. 28372
[3] Thermochimica Acta, [4] Thermochimica Acta, 1993, vol. 223, p. 207 - 212
[5] , Gmelin Handbook: F: PerFHalOrg.SVol.3, 6.2.3.1, page 48 - 120,

9
[ 563-63-3 ]
[ 2923-28-6 ]

Reference： [1] Journal of Organometallic Chemistry, 2000, vol. 600, # 1-2, p. 112 - 117

10
[ 2923-28-6 ]
[ 106-93-4 ]
[ 18928-34-2 ]
[ 103935-47-3 ]

Reference： [1] Journal of Fluorine Chemistry, 1985, vol. 29, p. 123

11
[ 2923-28-6 ]
[ 34946-82-2 ]

Reference： [1] Journal of Physical Chemistry B, 2005, vol. 109, # 48, p. 22890 - 22898

12
[ 2923-28-6 ]
[ 2926-29-6 ]
[ 811-68-7 ]

Yield	Reaction Conditions	Operation in experiment
84%	With tri-tert-butyl phosphine In acetonitrile at 0 - 20℃; for 12 h; Inert atmosphere	Under a nitrogen atmosphere, AgOTf (25.69 g, 100 mmol) and CF3SO2Na (18.73 g, 120 mmol) was dissolved in anhydrous acetonitrile (400 mL), the reaction solution was cooled to 0°C followed by the addition of tBu3P (50.58 g,250 mmol). The reaction solution was returned to room temperature, and stirred well at room temperature for 12 hours. After the reaction, the reaction solution was filtered through celite, the filtrate was cooled to -20 ° C, and crystals were precipitated. The supernatant was purged to remove most of the tri-tert-butylphosphine oxide. The supernatant was removed in vacuo to remove the solvent. The residue was washed thoroughly with ether, vacuum-dried and the residual solid was recrystallized from tetrahydrofuran and toluene to give the product trifluoromethylthio silver(I) (17.55 g, yield 84percent).

Reference： [1] Patent: CN105017110, 2016, B, . Location in patent: Paragraph 0037; 0038

13
[ 2923-28-6 ]
[ 58479-61-1 ]
[ 92886-86-7 ]

Reference： [1] Tetrahedron, 2004, vol. 60, # 38, p. 8375 - 8396
[2] Organic Letters, 2006, vol. 8, # 24, p. 5649 - 5652

[ 2923-28-6 ] Synthesis Path-Downstream 1~68

1
[ 2923-28-6 ]
[ 106-93-4 ]
[ 18928-34-2 ]
[ 103935-47-3 ]

Reference： [1]Journal of Fluorine Chemistry,1985,vol. 29,p. 123

3
[ 2369-18-8 ]
[ 2923-28-6 ]
[ 100-39-0 ]
1-benzyl-2-fluoro-3-methyl-pyridinium; trifluoro-methanesulfonate [ No CAS ]

Reference： [1]Journal of Organic Chemistry,2002,vol. 67,p. 7465 - 7474

4
[ 2923-28-6 ]
[ 58479-61-1 ]
[ 92886-86-7 ]

Reference： [1]Tetrahedron,2004,vol. 60,p. 8375 - 8396
[2]Organic Letters,2006,vol. 8,p. 5649 - 5652

5
[ 366-18-7 ]
nickel(II) chloride hexahydrate [ No CAS ]
[ 2923-28-6 ]
[ 19455-23-3 ]
hexaaqua nickel(II) trifluoromethanesulphonate [ No CAS ]
[Ni((C₅H₄N)2)2(H₂O)(OOCC(CH₃)3)]⁽¹⁺⁾*Cl^(1-)*H₂O=[Ni((C₅H₄N)2)2(H₂O)(OOCC(CH₃)3)]Cl*H₂O [ No CAS ]

Reference： [1]Russian Journal of Inorganic Chemistry,2000,vol. 45,p. 710 - 717

6
[ 15617-18-2 ]
[ 7732-18-5 ]
[ 2923-28-6 ]
[ 148461-16-9 ]
Pd(H₂O)2((C₆H₅)2PC₆H₄(C₃H₃(C(CH₃)3)NO))⁽²⁺⁾*2CF₃SO₃^(1-)=[Pd(H₂O)2((C₆H₅)2PC₆H₄(C₃H₃(C(CH₃)3)NO))](CF₃SO₃)2 [ No CAS ]

Reference： [1]Inorganica Chimica Acta,1999,vol. 296,p. 45 - 51

7
[ 109-99-9 ]
[ 12081-16-2 ]
[ 204203-16-7 ]
[ 2923-28-6 ]
[Rh(C₂₇H₃₁N₃)]⁽¹⁺⁾*CF₃SO₃^(1-)*0.25C₄H₈O=[Rh(C₂₇H₃₁N₃)](CF₃SO₃)*0.25C₄H₈O [ No CAS ]

Reference： [1]Organometallics,2001,vol. 20,p. 4345 - 4359

8
[ 72287-26-4 ]
[ 2923-28-6 ]
[Pd(II)(H₂O)2(1,1'-bis(diphenylphosphino)ferrocene)](CF₃SO₃)2 [ No CAS ]

Reference： [1]Organometallics,1996,vol. 15,p. 904 - 908

9
chloro(1,5-cyclooctadiene)rhodium(I) dimer [ No CAS ]
[ 22795-99-9 ]
[ 2923-28-6 ]
[Rh(cycloocta-1,5-diene)((-)-(S)-2-(aminomethyl)-1-ethylpyrrolidine)]CF₃SO₃ [ No CAS ]

Reference： [1]Helvetica Chimica Acta,2003,vol. 86,p. 1753 - 1759

10
dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer [ No CAS ]
[ 7732-18-5 ]
[ 2923-28-6 ]
[ 1867-73-8 ]
[(Rh(C5Me5)(μ-OH)(N-methyladenosine))2](CF3SO3)2*3H2O [ No CAS ]

Reference： [1]Journal of the Chemical Society, Dalton Transactions,2003,p. 380 - 386

11
ammonium hexafluorophosphate [ No CAS ]
[ 104413-90-3 ]
[ 2923-28-6 ]
[ 6622-91-9 ]
[Pt2(1,1'-bis(diphenylphosphino)ferrocene)2(μ-PyOAc)2](PF6)2*5H2O [ No CAS ]
silver(I) chloride [ No CAS ]

Reference： [1]Dalton Transactions,2004,p. 3389 - 3395

12
[ 104413-90-3 ]
[ 75-09-2 ]
[ 2923-28-6 ]
[ 6622-91-9 ]
[PtCl(1,1'-bis(diphenylphosphino)ferrocene)(PyOAcH)](triflate)*2CH₂Cl₂ [ No CAS ]
[Pt2(1,1'-bis(diphenylphosphino)ferrocene)2(μ-Cl)2](triflate)2 [ No CAS ]
silver(I) chloride [ No CAS ]

Reference： [1]Dalton Transactions,2004,p. 3389 - 3395

13
[ 21264-30-2 ]
[ 2923-28-6 ]
[ 174500-20-0 ]
PdCl(C₅H₃N(C₃H₃ONC₆H₅)2)⁽¹⁺⁾*CF₃SO₃^(1-)=[PdCl(C₅H₃N(C₃H₃ONC₆H₅)2)]CF₃SO₃ [ No CAS ]

Reference： [1]Journal of Organometallic Chemistry,1996,vol. 507,p. 85 - 101

14
bis(η3-allyl-μ-chloropalladium(II)) [ No CAS ]
[ 2923-28-6 ]
[ 174500-20-0 ]
Pd(C₅H₃N(C₃H₃ONC₆H₅)2)(C₃H₅)⁽¹⁺⁾*CF₃SO₃^(1-)=[Pd(C₅H₃N(C₃H₃ONC₆H₅)2)(C₃H₅)]CF₃SO₃ [ No CAS ]

Reference： [1]Journal of Organometallic Chemistry,1996,vol. 507,p. 85 - 101

15
[ 12354-84-6 ]
[ 2923-28-6 ]
[ 2133-40-6 ]
[Ir(C₅(CH₃)5)(C₄H₈NCOO)]2⁽²⁺⁾*2CF₃SO₃^(1-)=[Ir(C₅(CH₃)5)(C₄H₈NCOO)]2(CF₃SO₃)2 [ No CAS ]
silver(I) chloride [ No CAS ]

Reference： [1]Zeitschrift fur Anorganische und Allgemeine Chemie,1997,vol. 623,p. 1903 - 1911

16
[ 104413-90-3 ]
[ 2923-28-6 ]
[ 6622-91-9 ]
[Pt2(1,1'-bis(diphenylphosphino)ferrocene)2(μ-PyOAc)2](triflate)2 [ No CAS ]
silver(I) chloride [ No CAS ]

Reference： [1]Dalton Transactions,2004,p. 3389 - 3395

17
chloro(1,5-cyclooctadiene)rhodium(I) dimer [ No CAS ]
[ 2923-28-6 ]
[ 131833-93-7 ]
[Rh(1,5-COD)((S,S)-2,2'-isopropylidene-bis(4-tert-butyl-2-oxazoline))](CF₃SO₃) [ No CAS ]

Reference： [1]Organometallics,2006,vol. 25,p. 1749 - 1754

18
[osmium(II)dichloride(η6-p-cymene)]2 [ No CAS ]
[ 7732-18-5 ]
[ 2923-28-6 ]
[ 148461-14-7 ]
[(η6-p-MeC6H4(i)Pr)Os((4S)-2-(2-diphenylphosphinophenyl)-4-isopropyl-1,3-oxazoline)(H2O)](CF3SO3)2 [ No CAS ]

Reference： [1]Organometallics,2006,vol. 25,p. 1592 - 1606

19
di-μ-chlorobis{(2-phenylpyridine)palladium(II)} [ No CAS ]
[ 2923-28-6 ]
[ 142646-58-0 ]
[ 911849-88-2 ]

Reference： [1]Inorganic Chemistry Communications,2006,vol. 9,p. 93 - 95

20
di-μ-chlorobis{(7,7-benzoquinoline)palladium(II)} [ No CAS ]
[ 2923-28-6 ]
[ 142646-58-0 ]
[ 911849-99-5 ]

Reference： [1]Inorganic Chemistry Communications,2006,vol. 9,p. 93 - 95

21
[ 578743-87-0 ]
[ 2923-28-6 ]
IPrCuOTf [ No CAS ]

Reference： [1]Angewandte Chemie - International Edition,2015,vol. 54,p. 13734 - 13738
Angew. Chem.,2015,vol. 127,p. 13938 - 13942,5
[2]Journal of the American Chemical Society,2015,vol. 137,p. 1424 - 1427
[3]Organometallics,2006,vol. 25,p. 2237 - 2241

22
[ 1066-51-9 ]
[ 2923-28-6 ]
[Ag₆(aminomethylphosphonate)4(CF₃SO₃)2(H₂O)2]n [ No CAS ]

Reference： [1]Journal of Solid State Chemistry,2008,vol. 181,p. 1462 - 1471

23
ammonium hexafluorophosphate [ No CAS ]
[ 10199-34-5 ]
[ 2923-28-6 ]
[ 6622-91-9 ]
[ 75-05-8 ]
[Pt(4-pyridylacetate)(PPh₃)2]2(PF₆)(trifluoromethanesulfonate)*chloroform [ No CAS ]

Reference： [1]Inorganic Chemistry,2008,vol. 47,p. 6464 - 6474

24
[ 104413-90-3 ]
[ 67-66-3 ]
[ 2923-28-6 ]
[ 4385-76-6 ]
[ 75-05-8 ]
[ 1040733-26-3 ]
[PtCl(4-pyridylbenzoic acid)(1,1'-bis(diphenylphosphino)ferrocene)](trifluoromethanesulfonate)*0.75Et₂O*0.25chloroform [ No CAS ]

Reference： [1]Inorganic Chemistry,2008,vol. 47,p. 6464 - 6474

25
[ 39795-60-3 ]
[ 1050443-03-2 ]
[ 2923-28-6 ]
[Cp(*)2Ir2(μ-chloranilato)(4-(4-bromophenyl)pyridine)2](triflate)2 [ No CAS ]

Reference： [1]Organometallics,2008,vol. 27,p. 4088 - 4097

26
[ 1050443-03-2 ]
[ 2923-28-6 ]
[ 113682-56-7 ]
[Cp(*)4Ir4(μ-chloranilato)2(μ-1,4-bis(4-pyridyl)benzene)2](triflate)4 [ No CAS ]

Reference： [1]Organometallics,2008,vol. 27,p. 4088 - 4097

27
[ 42333-78-8 ]
[ 1039768-31-4 ]
[ 4877-80-9 ]
[ 2923-28-6 ]
[hexahydroxytriphenylene.cntnd.[Rh₆(p-Pr(i)C₆H₄CH₃)6(2,4,6-tri(pyridin-4-yl)-1,3,5-triazine)(2,5-dihydroxy-1,4-benzoquinonato)3]][O₃SCF₃]6 [ No CAS ]

Reference： [1]Zeitschrift fur Anorganische und Allgemeine Chemie,2008,vol. 634,p. 1349 - 1352

28
[ 42333-78-8 ]
[ 1039768-31-4 ]
[ 808-57-1 ]
[ 2923-28-6 ]
[hexamethoxytriphenylene.cntnd.[Rh₆(p-Pr(i)C₆H₄CH₃)6(2,4,6-tri(pyridin-4-yl)-1,3,5-triazine)(2,5-dihydroxy-1,4-benzoquinonato)3]][O₃SCF₃]6 [ No CAS ]

Reference： [1]Zeitschrift fur Anorganische und Allgemeine Chemie,2008,vol. 634,p. 1349 - 1352

29
dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer [ No CAS ]
[ 2645-22-9 ]
[ 2923-28-6 ]
[Cp(*)Rh(μ-4,4'-dipyridyldisulfide)Cl]2(OTf)2 [ No CAS ]

Reference： [1]Dalton Transactions,2010,vol. 39,p. 7119 - 7124

30
[ 2645-22-9 ]
[ 52462-29-0 ]
[ 2923-28-6 ]
[(p-cymene)Ru(μ-4,4'-dipyridyldisulfide)Cl]2(OTf)2 [ No CAS ]

Reference： [1]Dalton Transactions,2010,vol. 39,p. 7119 - 7124

31
[ 12354-84-6 ]
[ 2645-22-9 ]
[ 2923-28-6 ]
[Cp(*)Ir(μ-4,4'-dipyridyldisulfide)Cl]2(OTf)2 [ No CAS ]

Reference： [1]Dalton Transactions,2010,vol. 39,p. 7119 - 7124

32
[ 66-71-7 ]
[ 578743-87-0 ]
[ 2923-28-6 ]
[(1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene)Cu(1,10-phenathroline)][triflate] [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
61.4%		Chloro[l ,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]copper(I) (121.9 mg, 0.25 mmol) and silver triflate (64.2 mg, 0.25 mmol) were mixed under nitrogen in 25 mL flask and 10 mL of dry THF were added. Reaction mixture was stirred at RT for 30 minutes. Solution of 1 , 10-phenanthroline (45.05 mg, 0.25 mmol) in dry THF (5 mL) was added. Reaction mixture turned yellow and was stirred at RT overnight. Resulting mixture was filtered through Celite and solvent was evaporated on rotovap. Recrystallization from CH2Ch by vapor diffusion of Et20 gave 120 mg (61.4%) of yellow crystals. Anal, calcd. for C40H44CUF3N4O3S: C, 61.48; H, 5.68; N, 7.17; Found: C, 61.06; H, 5.61; N, 7.14. Structure was confirmed by IH-NMR spectrum of [(IPR)Cu(phen)]OTf (CDCb, 400MHz).

Reference： [1]Patent: WO2011/63083,2011,A1 .Location in patent: Page/Page column 83-84
[2]Chemical Communications,2010,vol. 46,p. 6696 - 6698

33
[ 2645-22-9 ]
3,3'-bis(2,4,6-tri-methylphenyl)-[(1,1'-diimidazolin-2,2'-diylidene)-methane]-palladium(II) dibromide [ No CAS ]
[ 2923-28-6 ]
[(1,1'-dimesityl-3,3'-methylenediimidazolin-2,2'-diylidene)Pd(4,4'-dithiodipyridine)]2(OTf)4 [ No CAS ]

Reference： [1]Organometallics,2010,vol. 29,p. 4842 - 4848

34
[ 14871-92-2 ]
[ 2923-28-6 ]
[ 158989-36-7 ]

Reference： [1]Organometallics,2010,vol. 29,p. 6002 - 6011

35
[ 2645-22-9 ]
[ 14783-09-6 ]
[ 7732-18-5 ]
[ 2923-28-6 ]
[(copper(II)(1,10-phenanthroline)(trifruoromethanesulfonate)2)2(μ-4,4'-dithiodipyridine)2] [ No CAS ]
[(copper(II)(1,10-phenanthroline)(trifruoromethanesulfonate)2)2(μ-4,4'-dithiodipyridine)2]*0.13H2O [ No CAS ]

Reference： [1]Zeitschrift fur Anorganische und Allgemeine Chemie,2011,vol. 637,p. 94 - 101

36
[ 2923-28-6 ]
[ 17875-18-2 ]
[ 1263876-15-8 ]

Reference： [1]Chemical Communications,2011,vol. 47,p. 779 - 781

37
[ 366-18-7 ]
[ 578743-87-0 ]
[ 2923-28-6 ]
[(IPR)Cu(bipy)]OTf [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
70.9%		Chloro[l,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]copper(I) (195.1 mg, 0.4 mmol) and silver triflate (102.7 mg, 0.4 mmol) were mixed under nitrogen in 25 mL flask and 10 mL of dry THF were added. Reaction mixture was stirred at RT for 30 minutes.Solution of 2,2'-bipyridine (62.4 mg, 0.4 mmol) in dry THF (5 mL) was added. Reaction mixture turned orange and was stirred at RT overnight. Resulting mixture was filtered through Celite and solvent was evaporated on rotovap. Recrystallization from CH2CI2 by vapor diffusion of EtaO gave 215 mg (70.9%) of orange crystals. Anal, calcd. forC38H44CUF3N4O3S: C, 60.26; H, 5.86; N, 7.40; Found: C, 60.18; H, 5.82; N, 7.38. Structure was confirmed by iH-NMR spectrum of [(IPR)Cu(bipy)]OTf (CDCb, 400MHz).

Reference： [1]Patent: WO2011/63083,2011,A1 .Location in patent: Page/Page column 84

38
[ 578743-87-0 ]
[ 13991-08-7 ]
[ 2923-28-6 ]
[(IPR)Cu(dppbz)]OTf [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
49.6%		Chloro[l ,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]copper(I) (487.59 mg, 0.25 mmol) and silver triflate (64.2 mg, 0.25 mmol) were mixed under nitrogen in 25 mL flask and 10 mL of dry THF were added. Reaction mixture was stirred at RT for 30 minutes. Solution of 1 ,2-bis(diphenylphosphino)benzene (1 1 1.6 mg, 0.25 mmol) in dry THF (5 mL) was added. Reaction mixture was stirred at RT overnight. Resulting mixture was filtered through Celite and solvent was evaporated on rotovap. Recrystallization from CH2CI2 by vapor diffusion of Et20 gave 130 mg (49.6%) of white needle crystals. Structure confirmed by 1H-NMR spectrum of [(IPR)Cu(dppbz)]OTf (CDCb, 400MHz).

Reference： [1]Patent: WO2011/63083,2011,A1 .Location in patent: Page/Page column 83

39
dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer [ No CAS ]
[ 2923-28-6 ]
[ 167316-27-0 ]
(Cp*RhTsDPEN)⁺CF₃SO₃^- [ No CAS ]

Reference： [1]Advanced Synthesis and Catalysis,2012,vol. 354,p. 3250 - 3258

40
[ 2923-28-6 ]
[ 173035-10-4 ]
[ 1004556-73-3 ]

Reference： [1]Organic Letters,2013,vol. 15,p. 996 - 999

41
[ 67-56-1 ]
dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer [ No CAS ]
[ 60-29-7 ]
Na₂(Cu(o-phenylenebis(oxamato))) [ No CAS ]
[ 7732-18-5 ]
[ 2923-28-6 ]
[ 113682-56-7 ]
12C₁₀H₁₅^(1-)*12Rh⁽³⁺⁾*6Cu⁽²⁺⁾*6C₁₀H₄N₂O₆^(4-)*6H₂O*17CH₄O*12CF₃O₃S^(1-)*2C₄H₁₀O*6C₁₆H₁₂N₂ [ No CAS ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 8125 - 8128

42
[ 37943-90-1 ]
[ 205319-10-4 ]
[ 2923-28-6 ]
xantphos(2-(diphenylphosphino)pyridine)palladium(II)bistriflate [ No CAS ]
xantphos(2-(diphenylphosphino)pyridine)platinum(II)bistriflate [ No CAS ]

Reference： [1]Dalton Transactions,2013,vol. 42,p. 6495 - 6512

43
Na₉[A-α-PW₉O₃₄] [ No CAS ]
[ 2923-28-6 ]
[ 174501-65-6 ]
(3,3-dimethylbut-1-yn-1-yl)silver [ No CAS ]
[Ag₇₀(PW₉O₃₄)₂(^tBuC≡C)₄₄(H2O)₂][BF4]₈*2[1-butyl-3-methylimidazolium]BF4*3H2O [ No CAS ]

Reference： [1]Chemical Communications,2014,vol. 50,p. 2353 - 2355

44
[ 2923-28-6 ]
[ 2927-34-6 ]
[ 1612253-27-6 ]

Reference： [1]Organic Letters,2014,vol. 16,p. 3372 - 3375

45
[Pd(η³-2-Me-C₃H₄)(μ-Cl)]₂ [ No CAS ]
[ 2923-28-6 ]
[ 13406-29-6 ]
(bis(tris(4-trifluoromethylphenyl))phosphino)palladium(η3-methallyl) triflate [ No CAS ]

Reference： [1]Journal of the American Chemical Society,2015,vol. 137,p. 7371 - 7378

46
[ 205319-10-4 ]
[ 2923-28-6 ]
[ 75-05-8 ]
Pd[(Xantphos)(CH₃CN)₂](OTf)₂ [ No CAS ]

Reference： [1]Journal of the American Chemical Society,2015,vol. 137,p. 12490 - 12493

47
bis[(1,2,3-η)-2-butenyl]di(μ-chloro)palladium(II) [ No CAS ]
[ 1070663-78-3 ]
[ 2923-28-6 ]
[(π-crotyl)Pd(BrettPhos)]OTf [ No CAS ]

Reference： [1]Journal of Organic Chemistry,2015,vol. 80,p. 6794 - 6813

48
bis[chloro(1,2,3-trihapto-allylbenzene)palladium(II)] [ No CAS ]
[ 1070663-78-3 ]
[ 2923-28-6 ]
[(π-cinnamyl)Pd(BrettPhos)]OTf [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
97%	In 2-methyltetrahydrofuran; for 0.5h;Schlenk technique; Inert atmosphere; Darkness;	General procedure: The general procedure is followed using 259 mg (0.50 mmol) of 33 [(cinnamyl)PdCl]2, 257 mg (1.00 mmol) of 22 AgOTf, 537 mg (1.00 mmol) of BrettPhos in anhydrous 2-MeTHF to give 884 mg (0.97 mmol, 97%) of the title compound as a yellow solid. 1H NMR (400 MHz, CDCl3, delta): complex spectrum-see FIG. 5. 13C NMR (100 MHz, CDCl3, delta): complex spectrum-see FIG. 6. 31P NMR (162 MHz, CDCl3, delta): 57.6, 39.5. 19F NMR (376 MHz, CDCl3, delta): -78.1 (s, 3F). Anal. Calcd. for C45H62F3O5PPdS: C, 59.43; H, 6.87. Found: C, 59.26; H, 6.68.

Reference： [1]Journal of Organic Chemistry,2015,vol. 80,p. 6794 - 6813
[2]Patent: US9777030,2017,B2 .Location in patent: Page/Page column 58; 64; 65

49
bis(η3-allyl-μ-chloropalladium(II)) [ No CAS ]
[ 1070663-78-3 ]
[ 2923-28-6 ]
[(π-allyl)Pd(BrettPhos)]OTf [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
94%	In tetrahydrofuran; for 0.5h;Schlenk technique; Inert atmosphere; Darkness;	General procedure: General Procedure A dry Schlenk flask equipped with a Teflon-coated magnetic stir bar is charged with [(R-allyl)PdC1]2 (0.50 mmol, 0.50 equiv) followed by AgOTf (257 mg, 1.00 mmol, 1.00 equiv). The flask is fitted with a rubber septum evacuated and backfilled with nitrogen. This evacuationlnitrogen back-fill cycle is repeated two additional times. Solvent (10 mE THF or 2-MeTHF) is added and the reaction mixture is stirred at it for 30 mm while protected from light. A second dry Schienk flask is equipped with a magnetic stir bar, fitted with a Schlenk frit, and charged with the appropriate ligand(1.00 mmol, 1.00 equiv). The flask is fitted with a rubber septum and it is evacuated and backfilled with nitrogen. This evacuationlnitrogen backfill cycle is repeated two additional times. The solution from the first Schlenk flask is transferred via cannula through the Schienk frit (to remove AgC1) andinto the second Schlenk flask containing the ligand, rinsing with 5 mE of additional solvent (THF or 2-MeTHF). This mixture is stirred at it for 2 h. 30 mE of hexanes is then added to fully precipitate the product. The solid materials are then collected by suction filtration, washed with additional pentane (or hexanes), and dried in vacuo; The general procedure is followed using 183 mg (0.50mmol) of [(allyl)PdC1]2, 257mg (1.00 mmol) ofAgOTf, 537mg (1.00 mmol) of l3rettPhos in anhydrous THF to give 803mg (0.94 mmol, 94%) of the title compound as a yellowsolid. The material contains 3 wt % of THF.?H NMR (400 MHz, CDC13, oe): 7.34 (s, 1H), 7.23 (s, 1H),7.07-6.98 (m, 1H), 6.96-6.87 (m, 1H), 5.45 (sept, J=7.52 Hz,1H), 4.14 (d, J=6.8 Hz, 1H), 3.84 (s, 3H), 3.42 (dd, J=8.2,13.1 Hz, 1H), 3.29 (s, 3H), 2.90 (sept, J=8.2 Hz, 1H),2.79-2.63 (m, 1H), 2.59 (d, J=13.2 Hz, 1H), 2.55-2.41 (m,1H), 2.40-2.25 (m, 2H), 2.14 (sept, J=7.8 Hz, 1H), 1.98-1.82(m, 2H), 1.81-0.93 (m, 29H), 0.92-0.66 (m, 7H).?3C NMR (100 MHz, CDC13, oe): 154.8 (2 peaks), 153.3,151.4, 150.5, 135.0, 134.8, 125.6, 124.9, 124.8, 124.2,123.9, 122.4, 119.5, 119.4, 119.3, 115.2, 113.7, 112.7 (2peaks), 100.7, 100.5, 55.8, 54.7, 52.0, 38.5, 38.4, 38.3, 38.1,33.7, 32.5, 31.5, 30.0, 27.2, 26.7, 26.6, 24.3, 24.0, 23.9, 23.8[Observed complexity due to C-P and C-F coupling];peaks attributable to THF are observed at 67.7 and 25.4.3?P NMR (162 MHz, CDC13, oe): 51.4.?9F NMR (376 MHz, CDC13, oe): -78.4 (s, 3F). Anal. Calcd. for C39H58F3O5PPdS: C, 56.21; H, 7.02. Found: C, 56.46; H, 7.05.

Reference： [1]Journal of Organic Chemistry,2015,vol. 80,p. 6794 - 6813
[2]Patent: US9777030,2017,B2 .Location in patent: Page/Page column 58; 64; 65

50
bis(η3-allyl-μ-chloropalladium(II)) [ No CAS ]
[ 2923-28-6 ]
[ 564483-19-8 ]
allyl(2-di-tert-butylphosphino-2‘,4‘,6‘-triisopropyl-1,1‘-biphenyl)palladium(II) triflate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
98%	In tetrahydrofuran; at 20℃; for 2h;Schlenk technique; Inert atmosphere; Darkness;	General procedure: [(allyl)PdCl]2 (183 mg, 0.50 mmol); 22 AgOTf (257 mg, 1.00 mmol); 27 tBuXPhos (425 mg, 1.00 mmol); 24 THF (10.0 mL); 2 h. Product obtained as a slightly yellow solid (708 mg, 98%); 1H NMR (400 MHz, CDCl3, delta): 7.92 (t, J=7.3 Hz, 1H), 7.59-7.47 (m, 3H), 7.42-7.40 (m, 1H), 6.79 (dd, J=3.2 Hz, 7.5 Hz, 1H), 5.72 (sept, J=7.2 Hz, 1H), 4.49 (d, J=6.7 Hz, 1H), 3.52 (dd, J=9.0 Hz, 14.0 Hz, 1H), 3.03 (quint, J=7.1 Hz, 1H), 2.93 (d, J=12.9 Hz, 1H), 2.67-2.62 (m, 1H), 2.50 (quint, J=7.1 Hz, 1H), 2.26 (quint, J=6.9 Hz, 1H), 1.49-1.40 (m, 9H), 1.40-1.28 (m, 21H), 0.96 (d, J=6.7 Hz, 3H), 0.88 (d, J=6.7 Hz, 3H); 13C NMR (100 MHz, CDCl3, delta): 153.6, 152.7, 149.2, 146.0, 145.8, 135.1 (2 peaks), 134.9, 133.7, 133.6, 131.7, 131.6, 128.3, 128.2, 126.6, 126.2, 125.8, 122.6, 120.3 (2 peaks), 120.1 (2 peaks), 119.4, 116.2, 101.3, 101.1, 55.5, 38.3 (2 peaks), 38.2, 38.1, 33.9, 32.0, 31.7, 31.2, 31.1, 30.9, 30.8, 25.9, 25.4, 24.9, 24.5 (2 peaks), 24.1 [Observed complexity due to C-F and C-P coupling]; 19F NMR (372 MHz, CDCl3, delta): -78.1 (s, 3F); 31P NMR (162 MHz, CDCl3, delta): 70.1; Anal. calcd. for C33H50O3F3PSPd: C, 54.96; H, 6.99. Found C, 54.84; H, 7.13.

Reference： [1]Patent: US9777030,2017,B2 .Location in patent: Page/Page column 58; 59; 60; 61
[2]Journal of Organic Chemistry,2015,vol. 80,p. 6794 - 6813

51
bis[(1,2,3-η)-2-butenyl]di(μ-chloro)palladium(II) [ No CAS ]
[ 2923-28-6 ]
[ 564483-19-8 ]
[(π-crotyl)Pd(tBuXPhos)]OTf [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
98%	In 2-methyltetrahydrofuran; at 20℃; for 2h;Schlenk technique; Inert atmosphere; Darkness;	General procedure: [(crotyl)PdCl]2 (197 mg, 0.50 mmol); 22 AgOTf (257 mg, 1.00 mmol); 27 tBuXPhos (425 mg, 1.00 mmol); 2-MeTHF (10.0 mL); 2 h. Product obtained as a slightly yellow solid (722 mg, 98%); The spectral properties are complicated due to the presence of isomers. 1H NMR (400 MHz, CDCl3, delta): Complex spectrum, see FIG. 1; 13C NMR (100 MHz, CDCl3, delta): 153.4, 152.3, 152.0, 146.4, 146.2, 146.0, 145.8, 144.1, 135.0, 134.9, 134.7, 134.4, 134.1, 133.7, 133.6, 133.3, 133.2, 131.5 (2 peaks), 131.4 (2 peaks), 128.1 (2 peaks), 128.0, 127.1, 126.1, 125.7, 124.6, 124.1, 122.9, 122.8, 122.5, 121.7, 121.4, 119.3, 112.9 (2 peaks), 48.3, 38.9, 38.8, 38.3, 38.1, 37.5, 37.3, 33.8, 33.5, 32.0, 31.9, 31.7, 31.6, 31.3, 31.1 (2 peaks), 31.0 (2 peaks), 30.7 (2 peaks), 26.2, 25.6, 25.5, 25.4, 25.1, 24.9, 24.3, 24.2, 24.0 (2 peaks), 23.7, 23.4, 22.8, 16.4 (2 peaks) [Observed complexity due to C-F and C-P coupling]; 19F NMR (372 MHz, CDCl3, delta): -77.9 (s, 3F); 31P NMR (162 MHz, CDCl3, delta): 72.2, 71.7, 66.7; Anal. calcd. for C34H52O3F3PSPd: C, 55.54; H, 7.13. Found C, 55.66; H, 6.99.

Reference： [1]Patent: US9777030,2017,B2 .Location in patent: Page/Page column 58; 59; 60; 61
[2]Journal of Organic Chemistry,2015,vol. 80,p. 6794 - 6813

52
bis[chloro(1,2,3-trihapto-allylbenzene)palladium(II)] [ No CAS ]
[ 2923-28-6 ]
[ 564483-19-8 ]
[(π-cinnamyl)Pd(tBuXPhos)]OTf [ No CAS ]

Reference： [1]Journal of Organic Chemistry,2015,vol. 80,p. 6794 - 6813

53
[ 301224-40-8 ]
[ 2923-28-6 ]
[ 603-35-0 ]
[imidazolidinylidene(mesityl)2]RuCl(PPh₃)[=CH-o-(OiPr)C₆H₄]OTf [ No CAS ]

Reference： [1]Dalton Transactions,2016,vol. 45,p. 3627 - 3634

54
dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer [ No CAS ]
[ 71071-46-0 ]
[ 2923-28-6 ]
C₂₄H₂₇ClN₂O₄Rh⁽¹⁺⁾*CF₃O₃S^(1-) [ No CAS ]

Reference： [1]European Journal of Inorganic Chemistry,2017,vol. 2017,p. 3024 - 3029

55
dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer [ No CAS ]
[ 17217-57-1 ]
[ 2923-28-6 ]
C₂₂H₂₇ClN₂O₂Rh⁽¹⁺⁾*CF₃O₃S^(1-) [ No CAS ]

Reference： [1]European Journal of Inorganic Chemistry,2017,vol. 2017,p. 3024 - 3029

56
[ 254-60-4 ]
potassium hexachloropalatinate(IV) [ No CAS ]
[ 2923-28-6 ]
[Pt(1,8-naphthyridine)₄](trifluoromethanesulfonate)₂ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
90%		In a round bottomed flask were placed 290 mg (0.70 mmol)K2PtCl4, 367 mg (2.8 mmol, 4 equivalents) <strong>[254-60-4]1,8-naphthyridine</strong>, and20 mL water. The Pt complex dissolved readily, whereas the naphthyridineremained largely insoluble, even after keeping the mixtureat reflux for three hours. The reaction mixture was thenallowed to cool to room temperature and diluted with 30 mL acetonitrile,which ensured complete dissolution. 724 mg (2.8 mmol,4 equivalents) AgOTf were then added, with immediate formationof a precipitate. The mixture was again refluxed for 6 h and thenfiltered. The filtrate was concentrated and the product precipitatedupon addition of diethylether. The resulting beige solid was recrystallizedfrom acetone/diethylether. Yield 90%. C34H24F6N8O6PtS2(1013.82): calcd. C 40.28, H 2.39, N 11.05, S 6.32; found C 40.45,H 2.46, N 10.74, S 6.71. 1H NMR (300 MHz, CD3CN): d = 7.39 (dd,3J = 8.1 and 5.5 Hz, 4 H, CH-3), 7.82 (dd, 3J = 8.1 and 4.4 Hz, 4 H,CH-6), 8.34 (dd, 3J = 8.1 Hz, 4J = 1.8 Hz, 4 H, CH-5), 8.38 (dd,3J = 8.1 Hz, 4J = 1.8 Hz, 4 H, CH-4), 9.62 (dd, 3J = 4.4 Hz, 4J = 1.8 Hz,4 H, CH-7), 10.14 (dd, 3J = 5.5 Hz, 4J = 1.8 Hz, 3JPtH = 41 Hz, 4 H,CH-2) ppm. 13C NMR (75 MHz, CD3CN): d = 122.7 (CH, C-3), 124.0(CH, C-6), 124.4 (C, C-9), 138.1 (CH, C-5), 141.4 (CH, C-4), 154.0(C, C-8), 155.6 (CH, C-7), 159.8 (CH, C-32) ppm. Crystals suitablefor X-ray structure determination were grown by slow evaporationof a dichloromethane solution of the complex.

Reference： [1]Inorganica Chimica Acta,2017,vol. 466,p. 578 - 583

57
[ 14096-51-6 ]
[ 2923-28-6 ]
[ 113682-56-7 ]
[(ethylenediamine)Pt(4,4′-1,4-phenylenebipyridine)]₄[trifluoromethanesulfonate]₈ [ No CAS ]

Reference： [1]Journal of the American Chemical Society,2017,vol. 139,p. 16913 - 16922

58
[ 55272-36-1 ]
[ 109073-77-0 ]
[ 2923-28-6 ]
[Ru(η⁵-MeCp)(PPh₃)(bpy(CH₂OH)2)][CF₃SO₃] [ No CAS ]

Reference： [1]Inorganic Chemistry,2018,vol. 57,p. 4629 - 4639

59
bis(η3-allyl-μ-chloropalladium(II)) [ No CAS ]
[ 1070663-78-3 ]
[ 2923-28-6 ]
C₃₇H₅₅O₂PPd⁽¹⁺⁾*CF₃O₃S^(1-) [ No CAS ]

Reference： [1]Organic Letters,2018,vol. 20,p. 2693 - 2697

60
[ 32993-05-8 ]
[ 109073-77-0 ]
[ 2923-28-6 ]
[Ru(η⁵-Cp)(PPh₃)(2,2′-bipyridine-4,4′-dimethanol)][CF₃SO₃] [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
50%	In dichloromethane; for 4h;Reflux; Inert atmosphere; Schlenk technique;	[Ru(eta5-Cp)(PPh3)(2,2'-bipyridine-4,4'-dimethanol)][CF3SO3] (Ru1) To a stirred suspension of 0.36?g (0.5?mmol) of [Ru(eta5-Cp)(PPh3)2Cl] in dichloromethane (30?mL), 0.13 (0.6?mmol) of 2,2'-bipyridine-4,4'-dimethanol were added followed by addition of 0.153?g (0.6?mmol) of AgCF3SO3. After refluxing for a period of 4?h the color changed slightly from orange to a darker orange. The reaction mixture was cooled down to room temperature and the solution was filtered to eliminate the AgCl and PPh3 precipitates. The solvent was then removed under vacuum. Ru1 was recrystallized once from dichloromethane/n-hexane and a second time from methanol/diethyl ether solution originating orange crystals. Yield?=?50%. 1H NMR - [MeOD, Me4Si, delta/ppm]: 9.21 [d, 2, 3JHH?=?4.0, H1], 7.92 [s, 2, H4], 7.36 [t, 3, 3JHH?=?8.0, Hpara(PPh3)], 7.25 [m, 8, H2+Hmeta(PPh3)], 7.01 [t, 6, 3JHH?=?8.0, Hortho(PPh3)], 4.74 [s, 5, eta5-C5H5], 4.69 [s, 4, C6]. 13C NMR [MeOD, Me4Si, delta/ppm]: 156.9, 156.8 (C1+C3), 153.5 (C5); 134.1 (2JCP?=?11, Cortho-PPh3); 133.1, 132.7 (Cq, PPh3); 131.2 (4JCP?=?2, Cpara-PPh3); 129.5 (3JCP?=?10, Cmeta-PPh3); 123.5 (C2); 121.3 (C4); 79.29 (2JCP?=?2, eta5-C5H5); 62.72 (C6). 31P NMR [MeOD, delta/ppm): 51.15 (s, PPh3). UV-Vis in CH2Cl2, lambdamax/nm (e/M-1cm-1): 473 (Sh), 414 (4026), 352 (Sh), 292 (20719). FTIR [KBr, cm-1]: 3410 (upsilonO-H), 3078-3057 (upsilonC-H Cp and aromatic rings), 2850 (upsilonC-H alkanes), 1616 and 1479 (upsilonC=C), 1248 (upsilon(CF3SO3-)), 1223 (upsilonC-O). Elemental analysis (%) Found: C, 53.7; H, 4.1; N, 3.4; S, 4.0. Calc. for C36H32N2PF3O5SRu: C, 54.5; H, 4.1; N, 3.5; S, 4.0. ESI-MS (+): calc. for [Ru1]+ m/z: 645.12, found m/z: 644.91.

Reference： [1]European Journal of Medicinal Chemistry,2019,vol. 163,p. 853 - 863

61
dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer [ No CAS ]
1,2,3‐triazole‐4,5‐dicarboxylate [ No CAS ]
[ 2923-28-6 ]
[ 113682-56-7 ]
C₈₀H₈₈N₁₀O₈Rh₄⁽²⁺⁾*2CF₃O₃S^(1-)*CH₄O [ No CAS ]

Reference： [1]Applied Organometallic Chemistry,2019,vol. 33

62
bis(η3-allyl-μ-chloropalladium(II)) [ No CAS ]
[ 1070663-78-3 ]
[ 2923-28-6 ]
[Pd(allyl)(BrettPhos)]OTf [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
86%		[Pd(allyl)(brettphos)]OTf was synthesized according to the literature.[4] A dry Schlenk flask equipped with a Teflon-coated magnetic stirring bar was charged with [(allyl)PdCl]2 (183 mg, 0.5 mmol) followed by AgOTf (257 mg, 1.0 mmol). The flask was fitted with a rubber septum, evacuated, and backfilled with nitrogen. This evacuation/nitrogen backfill cycle was repeated two additional times. Solvent (10 mLof THF) was added, and the reaction mixture was stirred at room temperature for 30min while protected from light. A second dry Schlenk flask was equipped with a magnetic stirring bar, fitted with a Schlenk frit, and charged with BrettPhos (537 mg,1.0 mmol). The flask was fitted with a rubber septum, and it was evacuated andbackfilled with nitrogen. This evacuation/nitrogen backfill cycle was repeated twoadditional times. The solution from the first Schlenk flask was transferred through amillipore filter (to remove AgCl) into the second Schlenk flask containing the ligand,rinsing with 5 mL of additional solvent (THF). This mixture was stirred at roomtemperature for 2 h. Hexanes (450 mL) was then added to the mixture to fullyprecipitate the product. The solid materials were then collected by suction filtration,washed with additional hexanes, and dried in vacuo to give 734 mg (86%) of the titlecompound as a yellow solid.

Reference： [1]Beilstein Journal of Organic Chemistry,2019,vol. 15,p. 542 - 550

63
[ 15224-11-0 ]
[ 2923-28-6 ]
[ 81290-20-2 ]
trans-ethyl 2-((trifluoromethoxy)methyl)cyclopropanecarboxylate [ No CAS ]
ethyl 2-((trifluoromethoxy)methyl)cyclopropanecarboxylate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	With potassium fluoride; 2-fluoropyridine; Selectfluor; In ethyl acetate; at 20℃; for 12.0h;Inert atmosphere;	To a solution of AgOTf (11.23 g, 43.70 mmol) in EtOAc (80 mL) at rt was added 1-(chloromethyl)-4-fluoro-1,4- diazoniabicyclo[2.2.2joctane;ditetrafluoroborate (7.74 g, 21.85 mmol), KF (3.39 g, 58.27 mmol) and <strong>[15224-11-0]ethyl 2-(hydroxymethyl)cyclopropanecarboxylate</strong> (2.1 g, 14.57 mmol). 2-fluoropyridine (4.24 g, 43.70 mmol) and trimethyl(trifluoromethyl)silane (6.21 g, 43.70 mmol) were added to this mixture and the resulting suspension was stirred at rt for 12 h. The reaction mixture was filtered through a pad of silica and was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (PE:EtOAc = 100:1 to 5:1) to provide ethyl 2- (trifluoromethoxymethyl)cyclopropanecarboxylate (cis: trans = 1:3).

Reference： [1]Patent: WO2019/46779,2019,A1 .Location in patent: Paragraph 0290; 0316

64
[(η⁶-p-cymene)RuCl(1,4-bis(dipyrrin-5-yl)benzene)_0.5]₂ [ No CAS ]
[ 2923-28-6 ]
[ 113682-56-7 ]
4CF₃O₃S^(1-)*C₁₂₀H₁₁₂N₁₂Ru₄⁽⁴⁺⁾ [ No CAS ]

Reference： [1]Inorganic Chemistry,2019,vol. 58,p. 4491 - 4499

65
[ 14871-92-2 ]
[ 2923-28-6 ]
[ 857296-36-7 ]
C₆₀H₄₀N₈Pd₂⁽⁴⁺⁾*4CF₃O₃S^(1-) [ No CAS ]

Reference： [1]Israel Journal of Chemistry,2019,vol. 59,p. 257 - 266

66
[ 2923-28-6 ]
[ 21948-70-9 ]
[Ag(2-(methylthio)pyrazine)(trifluoromethylsulfonate)]_n [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
88%	In methanol; at 20℃; for 0.5h;Darkness; Inert atmosphere;	General procedure: To a stirred solution of 2-(Methylthio)Pyrazine (0.013 g,0.10 mmol) in 5 mL of methanol, AgPF6 (0.051 g, 0.20 mmol) wasadded. Just after addition a white precipitate was formed and thereaction mixture was stirred for 30 min. The precipitate collectedand dried under vacuum. The white powder was dissolved in acetonitrileand kept for crystallization in dark. After few days colourlessrod shape crystals suitable for single crystal X-ray diffractionwere obtained. Yield: 0.059 g (79%). Anal. Calc. for C5H6N2F6PSAg:C, 15.85; H, 1.60; N, 7.39, Found: C, 15.52; H, 1.54; N, 8.03%. IR(KBr, cm1): 3067 (w), 2996 (w), 2924 (w), 1635 (w), 1507 (m),1468 (m), 1383 (m), 1299 (w), 1137 (s), 1046 (m), 1002 (m), 827(s), 561 (s). 1H NMR (DMSO, dppm): 2.53 (Me), 8.29, 8.47, 8.57(pyrazine ring). 13C NMR (DMSO, dppm): 12.68 (Me), 140.14,143.32, 144.83, 157.37 (pyrazine ring).

Reference： [1]Polyhedron,2019,vol. 169,p. 8 - 13

67
[ 14871-92-2 ]
p‑methyl‑N‑(4‑picolyl)‑azacalix[3.1.1.1]arene [ No CAS ]
[ 2923-28-6 ]
C₈₈H₈₈N₆O₈Pd⁽²⁺⁾*2CF₃O₃S^(1-) [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
46.0%		Direct synthesis from 1a, CF3SO3Ag, and [Pd(bipy)Cl2]. A solution of Pd(bipy)Cl2 (0.10 g, 0.30 mmol) in 5 mL of CH3CN and a solution of CF3SO3Ag (0.15 g, 0.58 mmol) in 5 mL of CH3CN were mixed and heated under reflux for a day. Precipitates were filtered off and the solvent was evaporated. The resultant pale yellow powder was dissolved in a mixture of CH3CN and CHCl3, and then 1a (0.35 g, 0.58 mmol) was added. The mixture was heated under reflux for a day, and then, filtered and the solvents were removed under reduced pressure. Resultant material was recrystallized from CH3CN- CHCl3 mixture twice. White fibers (0.27 g, 46.0%) were obtained. Mp. 249-252 C (dec.). 1H NMR ( CDCl3/CD3CN = 4/1, v/v, 300 MHz): delta 10.41 (brs, 8H, OH), 9.35 (brs, 4H, Py-H), 8.33 (d, J = 7.5 Hz, 2H, bipy-H), 8.26 (t, J = 7.0 Hz, 2H, bipy-H), 7.92 (brs, 4H, Py-H), 7.51 (t, 2H, bipy-H), 7.26 (d, J = 4.4 Hz, 2H, bipy- H), 6.99 (s, 4H, ArH), 6.95 (s, 4H, ArH), 6.89 (s, 4H, ArH), 6.67 (s, 4H, ArH), 4.11 (d, J = 13.8 Hz, 2H. CH2), 4.02 (d, J = 13.6 Hz, 4H. CH2), 3.80 (brs, 4H, CH2), 3.66 (brd, J = 10.8 Hz, 4H, CH2), 3.47 (brd, J = 13.8 Hz, 4H. CH2), 3.43 (brd, J = 12.9 Hz, 2H. CH2), 3.32 (d, J = 12.9 Hz, 4H, CH2), 2.19, 2.17 (s, 24H, CH3). 13C NMR ( CDCl3/CD3CN = 4/1, v/v, 75.6 MHz): delta 157.0, 153.2, 151.7, 150.7, 149.7, 147.2, 142.3, 131.2, 131.1, 130.0, 129.6, 129.5, 128.2, 128.0, 127.8, 127.8, 127.7, 124.2, 123.0, 121.0, 118.8, 57.7, 56.7, 32.0, 31.5, 20.5, 20.3. FABMS: m/z: 1611.5 ( M+); HRMS (FAB): calcd for C89H88F3N6O11S106Pd ( M2+ + TflO-), 1611.5219. Found: 1611.5231.

Reference： [1]Journal of Inclusion Phenomena and Macrocyclic Chemistry,2019,vol. 95,p. 235 - 246

68
[ 14243-64-2 ]
[ 2923-28-6 ]
[ 4967-77-5 ]
C₂₂H₂₀AuN₃O₂P⁽¹⁺⁾*CF₃O₃S^(1-) [ No CAS ]

Reference： [1]Inorganic Chemistry Communications,2019,vol. 109

Same Skeleton Products

Related Products

Historical Records

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]}	{[ getRatePrice(item.pr_usd, 1,1) ]}	{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]}	{[ item.pr_usastock ]}	Inquiry -	{[ item.pr_chinastock ]}	Inquiry -

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

[ CAS No. 2923-28-6 ]

Quality Control of [ 2923-28-6 ]

Related Doc. of [ 2923-28-6 ]

Product Details of [ 2923-28-6 ]

Calculated chemistry of [ 2923-28-6 ]

Physicochemical Properties

Pharmacokinetics

Lipophilicity

Druglikeness

Water Solubility

Medicinal Chemistry

Safety of [ 2923-28-6 ]

Application In Synthesis of [ 2923-28-6 ]

[ 2923-28-6 ] Synthesis Path-Upstream 1~13

[ 2923-28-6 ] Synthesis Path-Downstream 1~68

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry